Dydrogesterone - clinical benefits of its metabolic neutrality

Abstract

Progestagens have oferent biologic affects which must be included into therapeutic choice. The best progestogen for the hormone replacement therapy could be metabolic neutral and safe for breast tissue.

Micronised progesterone and dydrogesterone have better safety profile than synthetic progestagens. Also during pregnancy we prefer natural gestagens to synthetic ones.

Keywords

• dydrogesterone
• early pregnancy loss
• hormone replacement therapy
• menstrual cycle disturbance
• preterm labor